Medical and Health Science Journal

  Previous Article | Back to Volume | Next Article
  Abstract | References | Citation | Download | Preview | Statistics
Volume 6
Issue 2
Online publication date 2011-04-04
Title Risk stratification for patients with unstable angina pectoris with concomitant type 2 diabetes mellitus
Author Raisa Trigulova, Ravshanbek Kurbanov
Abstract The work was initiated to assess a relation between glycemia control adequacy and dyslipidemia correction by statins in the medically treated diabetics with 2-year unstable angina pectoris outcome. 29 patients with newly diagnosed and progressing angina pectoris were examined and followed-up for 2 years. Fatal and non-fatal myocardial infarction, stroke, sudden death, emergent rehospitalization were among the disease unfavorable outcomes. The findings demonstrated confident differences in the initial postprandial glycemia differential (PGD) in patients with the disease favorable course. In the group of patients with the disease favorable course proportion of persons with mild PGD increment (not more than 27.7%) comes up to more than a half, to be significantly (5 times)  and confidently higher than in patients with the adverse disease. The fact per se allows considering mild PGD increment as a discriminating marker for setting aside patients with the disease favorable course positively responding to statin therapy.
Abraham, E., Huff, T., Copen, D., et al., 1978. “Determination of the glycosylation hemoglobins (HbA1c) with a new microcolum procedure,” Diabetes, Vol.27, (9), pp.931-37

Ametov, A., Sokareva, E., 2007. “Statins in the prevention and management of type 2 diabetes,” Russian Journal of Medicine [Russkiy Medicinskiy Jurnal], in Russian, Vol.15,(11), pp.922-24

Anderson, J., Adams, C., Antman, E. et al., 2007. “Guidelines for the Management of Patients With Unstable Angina/Non–ST–Elevation Myocardial Infarction. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines”, JACC, Vol.50, pp.81-157

Bassand, J., Hamm, C., Adrissino, D. et al., 2007. “Guidelines for the diagnosis and treatment of non -ST-segment elevation acute coronary syndromes,” The Task Force for the Diagnosis and Treatment of Non - ST - Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology, European Heart Journal, Vol.14, pp.1-63

Bays, H., 2005. “Collaborative Atorvastatin Diabetes Study (CARDS),” Lipids Online Commentaries on Research. Available at:, Accessed at March, 2011
Dedov, I., Shestakova, M., 2005. “Prevention of and struggle with social diseases. Federal Target Program, “Diabetes mellitus” subprogram: diabetes mellitus and cardiovascular disorders: Problem state- of- the- art”, Diabetes mellitus [Saharniy Diabet], in Russian, Vol.7, pp.1-13

Fluchiger, K., Winterhalter, K., 1976. “In vitro synthesis of hemoglobin A 1c,” Febs Lett., Vol.71, pp.356-60

Glinkina, I., Zilov, A., Melnichenko G., et al., 2008. “Comparative effect of carbohydrate metabolism compensation and therapy with atorvastatin on lipid metabolism and C-reactive protein in type 2 diabetes mellitus,” Therapeutic archive [Terapevticheskiy Archiv], in Russian, Vol.12, pp. 17-22

Klimov, А., Dеев, А., Shestov, D., Williams, О., 1983. “Lipid values and indexes estimation during the coronary disease”, Cardiology [Kardiologiya], in Russian, Vol.10, pp.82-88

Nesukai, Е., Ponomaryova, G., 2007. “Results of study of atorvastatin efficiency and safety in patients with dyslipidemia,” Ukrainian Journal of Cardiology [Ukrainskiy Kardiologicheskiy Jurnal], in Russian, Vol.3, pp.29-31

Packard, C., 2004. “Improving outcomes through statin therapy - a review of ongoing trials,” Eur. Hert J., Vol.6, Suppl A, pp.A38-A31

Pitt, B., Waters, D., Brown, W. et al., 1999. “Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment (AVERT) Investigators,” New Engl. J. Med., Vol.341, pp.70-76

Ryden, L., Standl, E., Bartnik, M. et al., 2007. “Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary,” The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD), Eur Heart J., (28), pp.88-136

Schwartz, G., Olsson, A., Ezekowitz, M. et al., 2001. “Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial,” JAMA (285), pp.1711-718
Sever, P., Dahlof, B., Poulter, N. et al., 2003. “Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average of lower-than - average cholesterol concentration, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipids Lowering Arm (ASCOT-LLA),” Lancet, Vol.361, pp.1149-158
Stenestrand, U., Wallentin, L., 2001. “Early statin treatment following acute myocardial infarction and 1-year survival,” JAMA, Vol.285(5), pp.430-36

Trigulova, R., 2006. “Efficiency of insulin therapy in patients with unstable angina pectoris and type 2 diabetes mellitus,” Russian National Congress of Cardiologists, “Cardiovascular therapy and prevention, Supplement” [Prilojenie k jurnalu “Kardiovaskulqrnaya terapiya i profilaktika”], in Russian, Vol.5, pp.376

Vertkin, A., Prokhorovich, A., Kulnichenko, T., 2006. “The role of statins in patients with acute syndromes without ST segment elevation ST,” Farmateka: Medical Journal [Farmateka: Medicinskiy Jurnal], in Russian, Vol.20, pp.63-69

Volkov, V., Serik, S., Stepanova, 2008. “Opportunities for statins in the prevention of coronary heart disease in patients with diabetes: A review,” Ukrainian Journal of Cardiology [Ukrainskiy Kardiologicheskiy Jurnal], in Russian, (3), pp. 18-27

Waters, D., Guyton, J., Herrington, D., 2004. “Treating to New Targets (TNT) Study: Does lowering low-density lipoprotein cholesterol levels below currently recommended guidelines yield incremental clinical benefit?”, Amer. J. Cardiology, Vol.93, pp.154-58

Keywords Unstable angina pectoris, type 2 diabetes mellitus, atorvastatin, postprandial glycemia differential
Pages 29-34
Download Full PDF Download
  Previous Article | Back to Volume | Next Article
Search in articles
Journal Published articles
MHSJ 940
Journal Hits
MHSJ 2566652
Journal Downloads
MHSJ 17488
Total users online -